类似葡萄糖类-1是急性呼吸系统衰竭中死亡率的预后
Cole E Hansell1, Hamam A Aneis2, Georgios D Kitsios3,4,5
1Department of Medicine, UPMC Presbyterian-Shadyside Hospitals, Pittsburgh, PA.
Critical care explorations
|March 24, 2025
概括
在急性呼吸衰竭患者中,较高的葡萄糖类-1 (GLP-1) 水平表明死亡风险增加和全身炎症. 葡萄糖依赖胰岛素 (GIP) 水平没有显示出这种关联,这表明GLP-1是潜在的预后生物标志物.
科学领域:
- 内分泌学 在内分泌学.
- 关键护理医学 关键护理医学
- 肺部病理学 肺部病理学
背景情况:
- 胰岛素激素,葡萄糖类-1 (GLP-1) 和依赖葡萄糖的胰岛素 (GIP),以它们在糖尿病治疗中的治疗作用而闻名.
- 之前的研究表明,因克列水平可能预测危急病患者的不良结果.
- 急性呼吸衰竭是一种常见的和严重的疾病,在重症监护室 (ICU) 遇到.
研究的目的:
- 调查是否可以作为疾病严重程度和急性呼吸衰竭患者的临床结果的指标的素激素水平 (GLP-1和GIP).
- 在这个患者群体中,探索英克雷丁水平与全身炎症和肠道透性标记物之间的关联.
主要方法:
- 进行了一项回顾性队列研究,涉及297名入住ICU的急性呼吸衰竭的危急病人.
- 采集了基线血液样本以测量GLP-1和GIP水平.
- 包括后勤回归在内的统计分析被用来评估英克雷丁水平与90天死亡率之间的关联,并根据相关的共同变量进行调整,如年龄,序列器官衰竭评估得分和介质蛋白-6水平.
主要成果:
- 在非幸存者和患有或有急性呼吸窘迫综合征 (ARDS) 风险的患者中观察到GLP-1水平升高,与用于呼吸道保护的患者相比.
- GLP-1水平与系统性免疫反应的生物标志物有正相关性,但与肠道透性的标志物没有.
- 在未调整和调整的分析中,GLP-1水平和90天死亡率之间发现了显著的正相关性 (OR 2.02;95% CI 1.23-3.31).
- GIP水平与死亡率或宿主反应生物标志物之间没有发现显著的关联.
结论:
- 循环GLP-1水平,但不是GIP水平,在急性呼吸衰竭的重症患者中与全身炎症和死亡风险增加有关.
- 升高的GLP-1可能起到预后生物标志物的作用,有助于识别在这种危急疾病环境中更有可能出现不良结果的患者.
相关概念视频
Glucagon-like Receptor Agonists
277
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
277
Hypoglycemia and Glucagon
143
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
143
Acute Respiratory Failure-V
113
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
113
Acute Pancreatitis II: Clinical Manifestations and Management
76
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
76
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
39
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
39
Hormones Regulating Blood Glucose
2.9K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
2.9K


